A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

Update Il y a 4 ans
Reference: NCT00812799

Woman and Man

Extract

This study will be performed to determine the long-term efficacy of 19.000 BU Oralgen grass pollen administered daily in patients with grass pollen related allergic rhinoconjunctivitis.


Inclusion criteria

  • Allergic Rhinoconjunctivitis


Links